Industry Research Reports

Home > Reports > Pharma & Healthcare > C1 Esterase Inhibitor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

C1 Esterase Inhibitor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-24

Pages: 82 Pages

Report ld: 2341668

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

C1 Esterase Inhibitor Market Size(US$)

CAGR 2024-2030

6.1%

Market Size,2030

USD 194

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 136 million

Market Forecast in 2030(Value)

US$ 194 million

CAGR

6.1%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.

The global market for C1 Esterase Inhibitor was estimated to be worth US$ 128.6 million in 2023 and is forecast to a readjusted size of US$ 194 million by 2030 with a CAGR of 6.1% during the forecast period 2024-2030

The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.

MARKET SEGMENTATION

By Company

CSL Behring
Takeda
Pharming Intellectual

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Human
Recombinant

Segment by Application

Hospital
Pharmacy

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for C1 Esterase Inhibitor, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of C1 Esterase Inhibitor by region & country, by Type, and by Application.

The C1 Esterase Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C1 Esterase Inhibitor.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of C1 Esterase Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of C1 Esterase Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of C1 Esterase Inhibitor in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 C1 Esterase Inhibitor Product Introduction

1.2 Global C1 Esterase Inhibitor Market Size Forecast

1.2.1 Global C1 Esterase Inhibitor Sales Value (2019-2030)

1.2.2 Global C1 Esterase Inhibitor Sales Volume (2019-2030)

1.2.3 Global C1 Esterase Inhibitor Sales Price (2019-2030)

1.3 C1 Esterase Inhibitor Market Trends & Drivers

1.3.1 C1 Esterase Inhibitor Industry Trends

1.3.2 C1 Esterase Inhibitor Market Drivers & Opportunity

1.3.3 C1 Esterase Inhibitor Market Challenges

1.3.4 C1 Esterase Inhibitor Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global C1 Esterase Inhibitor Players Revenue Ranking (2023)

2.2 Global C1 Esterase Inhibitor Revenue by Company (2019-2024)

2.3 Global C1 Esterase Inhibitor Players Sales Volume Ranking (2023)

2.4 Global C1 Esterase Inhibitor Sales Volume by Company Players (2019-2024)

2.5 Global C1 Esterase Inhibitor Average Price by Company (2019-2024)

2.6 Key Manufacturers C1 Esterase Inhibitor Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers C1 Esterase Inhibitor Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of C1 Esterase Inhibitor

2.9 C1 Esterase Inhibitor Market Competitive Analysis

2.9.1 C1 Esterase Inhibitor Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by C1 Esterase Inhibitor Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Human

3.1.2 Recombinant

3.2 Global C1 Esterase Inhibitor Sales Value by Type

3.2.1 Global C1 Esterase Inhibitor Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global C1 Esterase Inhibitor Sales Value, by Type (2019-2030)

3.2.3 Global C1 Esterase Inhibitor Sales Value, by Type (%) (2019-2030)

3.3 Global C1 Esterase Inhibitor Sales Volume by Type

3.3.1 Global C1 Esterase Inhibitor Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global C1 Esterase Inhibitor Sales Volume, by Type (2019-2030)

3.3.3 Global C1 Esterase Inhibitor Sales Volume, by Type (%) (2019-2030)

3.4 Global C1 Esterase Inhibitor Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.2 Global C1 Esterase Inhibitor Sales Value by Application

4.2.1 Global C1 Esterase Inhibitor Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global C1 Esterase Inhibitor Sales Value, by Application (2019-2030)

4.2.3 Global C1 Esterase Inhibitor Sales Value, by Application (%) (2019-2030)

4.3 Global C1 Esterase Inhibitor Sales Volume by Application

4.3.1 Global C1 Esterase Inhibitor Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global C1 Esterase Inhibitor Sales Volume, by Application (2019-2030)

4.3.3 Global C1 Esterase Inhibitor Sales Volume, by Application (%) (2019-2030)

4.4 Global C1 Esterase Inhibitor Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global C1 Esterase Inhibitor Sales Value by Region

5.1.1 Global C1 Esterase Inhibitor Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global C1 Esterase Inhibitor Sales Value by Region (2019-2024)

5.1.3 Global C1 Esterase Inhibitor Sales Value by Region (2025-2030)

5.1.4 Global C1 Esterase Inhibitor Sales Value by Region (%), (2019-2030)

5.2 Global C1 Esterase Inhibitor Sales Volume by Region

5.2.1 Global C1 Esterase Inhibitor Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global C1 Esterase Inhibitor Sales Volume by Region (2019-2024)

5.2.3 Global C1 Esterase Inhibitor Sales Volume by Region (2025-2030)

5.2.4 Global C1 Esterase Inhibitor Sales Volume by Region (%), (2019-2030)

5.3 Global C1 Esterase Inhibitor Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America C1 Esterase Inhibitor Sales Value, 2019-2030

5.4.2 North America C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe C1 Esterase Inhibitor Sales Value, 2019-2030

5.5.2 Europe C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific C1 Esterase Inhibitor Sales Value, 2019-2030

5.6.2 Asia Pacific C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America C1 Esterase Inhibitor Sales Value, 2019-2030

5.7.2 South America C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa C1 Esterase Inhibitor Sales Value, 2019-2030

5.8.2 Middle East & Africa C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions C1 Esterase Inhibitor Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions C1 Esterase Inhibitor Sales Value

6.2.1 Key Countries/Regions C1 Esterase Inhibitor Sales Value, 2019-2030

6.2.2 Key Countries/Regions C1 Esterase Inhibitor Sales Volume, 2019-2030

6.3 United States

6.3.1 United States C1 Esterase Inhibitor Sales Value, 2019-2030

6.3.2 United States C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.3.3 United States C1 Esterase Inhibitor Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe C1 Esterase Inhibitor Sales Value, 2019-2030

6.4.2 Europe C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe C1 Esterase Inhibitor Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China C1 Esterase Inhibitor Sales Value, 2019-2030

6.5.2 China C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.5.3 China C1 Esterase Inhibitor Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan C1 Esterase Inhibitor Sales Value, 2019-2030

6.6.2 Japan C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan C1 Esterase Inhibitor Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea C1 Esterase Inhibitor Sales Value, 2019-2030

6.7.2 South Korea C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea C1 Esterase Inhibitor Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia C1 Esterase Inhibitor Sales Value, 2019-2030

6.8.2 Southeast Asia C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia C1 Esterase Inhibitor Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India C1 Esterase Inhibitor Sales Value, 2019-2030

6.9.2 India C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

6.9.3 India C1 Esterase Inhibitor Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CSL Behring

7.1.1 CSL Behring Company Information

7.1.2 CSL Behring Introduction and Business Overview

7.1.3 CSL Behring C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

7.1.4 CSL Behring C1 Esterase Inhibitor Product Offerings

7.1.5 CSL Behring Recent Development

7.2 Takeda

7.2.1 Takeda Company Information

7.2.2 Takeda Introduction and Business Overview

7.2.3 Takeda C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Takeda C1 Esterase Inhibitor Product Offerings

7.2.5 Takeda Recent Development

7.3 Pharming Intellectual

7.3.1 Pharming Intellectual Company Information

7.3.2 Pharming Intellectual Introduction and Business Overview

7.3.3 Pharming Intellectual C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Pharming Intellectual C1 Esterase Inhibitor Product Offerings

7.3.5 Pharming Intellectual Recent Development

8 Industry Chain Analysis

8.1 C1 Esterase Inhibitor Industrial Chain

8.2 C1 Esterase Inhibitor Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 C1 Esterase Inhibitor Sales Model

8.5.2 Sales Channel

8.5.3 C1 Esterase Inhibitor Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. C1 Esterase Inhibitor Market Trends

Table 2. C1 Esterase Inhibitor Market Drivers & Opportunity

Table 3. C1 Esterase Inhibitor Market Challenges

Table 4. C1 Esterase Inhibitor Market Restraints

Table 5. Global C1 Esterase Inhibitor Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global C1 Esterase Inhibitor Revenue Market Share by Company (2019-2024)

Table 7. Global C1 Esterase Inhibitor Sales Volume by Company (2019-2024) & (K Unit)

Table 8. Global C1 Esterase Inhibitor Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market C1 Esterase Inhibitor Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers C1 Esterase Inhibitor Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers C1 Esterase Inhibitor Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of C1 Esterase Inhibitor

Table 13. Global C1 Esterase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global C1 Esterase Inhibitor Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global C1 Esterase Inhibitor Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global C1 Esterase Inhibitor Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global C1 Esterase Inhibitor Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global C1 Esterase Inhibitor Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global C1 Esterase Inhibitor Sales Volume by Type: 2019 VS 2023 VS 2030 (K Unit)

Table 22. Global C1 Esterase Inhibitor Sales Volume by Type (2019-2024) & (K Unit)

Table 23. Global C1 Esterase Inhibitor Sales Volume by Type (2025-2030) & (K Unit)

Table 24. Global C1 Esterase Inhibitor Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global C1 Esterase Inhibitor Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global C1 Esterase Inhibitor Price by Type (2019-2024) & (USD/Unit)

Table 27. Global C1 Esterase Inhibitor Price by Type (2025-2030) & (USD/Unit)

Table 28. Global C1 Esterase Inhibitor Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global C1 Esterase Inhibitor Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global C1 Esterase Inhibitor Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global C1 Esterase Inhibitor Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global C1 Esterase Inhibitor Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global C1 Esterase Inhibitor Sales Volume by Application: 2019 VS 2023 VS 2030 (K Unit)

Table 34. Global C1 Esterase Inhibitor Sales Volume by Application (2019-2024) & (K Unit)

Table 35. Global C1 Esterase Inhibitor Sales Volume by Application (2025-2030) & (K Unit)

Table 36. Global C1 Esterase Inhibitor Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global C1 Esterase Inhibitor Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global C1 Esterase Inhibitor Price by Application (2019-2024) & (USD/Unit)

Table 39. Global C1 Esterase Inhibitor Price by Application (2025-2030) & (USD/Unit)

Table 40. Global C1 Esterase Inhibitor Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global C1 Esterase Inhibitor Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global C1 Esterase Inhibitor Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global C1 Esterase Inhibitor Sales Value by Region (2019-2024) & (%)

Table 44. Global C1 Esterase Inhibitor Sales Value by Region (2025-2030) & (%)

Table 45. Global C1 Esterase Inhibitor Sales Volume by Region (K Unit): 2019 VS 2023 VS 2030

Table 46. Global C1 Esterase Inhibitor Sales Volume by Region (2019-2024) & (K Unit)

Table 47. Global C1 Esterase Inhibitor Sales Volume by Region (2025-2030) & (K Unit)

Table 48. Global C1 Esterase Inhibitor Sales Volume by Region (2019-2024) & (%)

Table 49. Global C1 Esterase Inhibitor Sales Volume by Region (2025-2030) & (%)

Table 50. Global C1 Esterase Inhibitor Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global C1 Esterase Inhibitor Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions C1 Esterase Inhibitor Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions C1 Esterase Inhibitor Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions C1 Esterase Inhibitor Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions C1 Esterase Inhibitor Sales Volume, (2019-2024) & (K Unit)

Table 56. Key Countries/Regions C1 Esterase Inhibitor Sales Volume, (2025-2030) & (K Unit)

Table 57. CSL Behring Company Information

Table 58. CSL Behring Introduction and Business Overview

Table 59. CSL Behring C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. CSL Behring C1 Esterase Inhibitor Product Offerings

Table 61. CSL Behring Recent Development

Table 62. Takeda Company Information

Table 63. Takeda Introduction and Business Overview

Table 64. Takeda C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Takeda C1 Esterase Inhibitor Product Offerings

Table 66. Takeda Recent Development

Table 67. Pharming Intellectual Company Information

Table 68. Pharming Intellectual Introduction and Business Overview

Table 69. Pharming Intellectual C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Pharming Intellectual C1 Esterase Inhibitor Product Offerings

Table 71. Pharming Intellectual Recent Development

Table 72. Key Raw Materials Lists

Table 73. Raw Materials Key Suppliers Lists

Table 74. C1 Esterase Inhibitor Downstream Customers

Table 75. C1 Esterase Inhibitor Distributors List

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. C1 Esterase Inhibitor Product Picture

Figure 2. Global C1 Esterase Inhibitor Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global C1 Esterase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 4. Global C1 Esterase Inhibitor Sales Volume (2019-2030) & (K Unit)

Figure 5. Global C1 Esterase Inhibitor Sales Price (2019-2030) & (USD/Unit)

Figure 6. C1 Esterase Inhibitor Report Years Considered

Figure 7. Global C1 Esterase Inhibitor Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global C1 Esterase Inhibitor Players Sales Volume Ranking (2023) & (K Unit)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by C1 Esterase Inhibitor Revenue in 2023

Figure 10. C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Human Picture

Figure 12. Recombinant Picture

Figure 13. Global C1 Esterase Inhibitor Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global C1 Esterase Inhibitor Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global C1 Esterase Inhibitor Sales Volume by Type (2019 VS 2023 VS 2030) & (K Unit)

Figure 16. Global C1 Esterase Inhibitor Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global C1 Esterase Inhibitor Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Pharmacy

Figure 20. Global C1 Esterase Inhibitor Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global C1 Esterase Inhibitor Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global C1 Esterase Inhibitor Sales Volume by Application (2019 VS 2023 VS 2030) & (K Unit)

Figure 23. Global C1 Esterase Inhibitor Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global C1 Esterase Inhibitor Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America C1 Esterase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 26. North America C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe C1 Esterase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific C1 Esterase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 31. South America C1 Esterase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 32. South America C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa C1 Esterase Inhibitor Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa C1 Esterase Inhibitor Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions C1 Esterase Inhibitor Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions C1 Esterase Inhibitor Sales Volume (%), (2019-2030)

Figure 37. United States C1 Esterase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 39. United States C1 Esterase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe C1 Esterase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe C1 Esterase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 43. China C1 Esterase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 44. China C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 45. China C1 Esterase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan C1 Esterase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan C1 Esterase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea C1 Esterase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea C1 Esterase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia C1 Esterase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia C1 Esterase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 55. India C1 Esterase Inhibitor Sales Value, (2019-2030) & (US$ Million)

Figure 56. India C1 Esterase Inhibitor Sales Value by Type (%), 2023 VS 2030

Figure 57. India C1 Esterase Inhibitor Sales Value by Application (%), 2023 VS 2030

Figure 58. C1 Esterase Inhibitor Industrial Chain

Figure 59. C1 Esterase Inhibitor Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global C1 Esterase Inhibitor market? zhanKai

The top companies in the global C1 Esterase Inhibitor market are CSL Behring、Takeda、Pharming Intellectual.

What was the global market size of C1 Esterase Inhibitor in 2030? shouQi

What is the annual compound growth rate of the global C1 Esterase Inhibitor market size from 2024 to 2030? shouQi

What was the global market size of C1 Esterase Inhibitor in 2024? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 151 million in 2025 and is projected to reach US$ 228 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 123
USD 3950.00
(Single User License)
Global C1 Esterase Inhibitor Market Research Report 2026
The global C1 Esterase Inhibitor market was valued at US$ 151 million in 2025 and is anticipated to reach US$ 228 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 104
USD 2900.00
(Single User License)
Global C1 Esterase Inhibitor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global C1 Esterase Inhibitor market size was US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 71
USD 4250.00
(Single User License)
C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 80
USD 3950.00
(Single User License)
Global C1 Esterase Inhibitor Market Research Report 2025
The global market for C1 Esterase Inhibitor was valued at US$ 143 million in the year 2024 and is projected to reach a revised size of US$ 216 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published Date: 2025-02-25
Pages: 71
USD 2900.00
(Single User License)
Global C1 Esterase Inhibitor Market Insights, Forecast to 2030
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published Date: 2024-04-25
Pages: 79
USD 4900.00
(Single User License)
Global C1 Esterase Inhibitor Market Research Report 2024
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published Date: 2024-01-05
Pages: 72
USD 2900.00
(Single User License)

C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 151 million in 2025 and is projected to reach US$ 228 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 123
USD 3950.00 (Single User License)
Global C1 Esterase Inhibitor Market Research Report 2026
The global C1 Esterase Inhibitor market was valued at US$ 151 million in 2025 and is anticipated to reach US$ 228 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 104
USD 2900.00 (Single User License)
Global C1 Esterase Inhibitor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global C1 Esterase Inhibitor market size was US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 71
USD 4250.00 (Single User License)
C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 80
USD 3950.00 (Single User License)
Global C1 Esterase Inhibitor Market Research Report 2025
The global market for C1 Esterase Inhibitor was valued at US$ 143 million in the year 2024 and is projected to reach a revised size of US$ 216 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published: 2025-02-25
Pages: 71
USD 2900.00 (Single User License)
Global C1 Esterase Inhibitor Market Insights, Forecast to 2030
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published: 2024-04-25
Pages: 79
USD 4900.00 (Single User License)
Global C1 Esterase Inhibitor Market Research Report 2024
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published: 2024-01-05
Pages: 72
USD 2900.00 (Single User License)